Recent Quarter Total Invested
$114.33 M
Recent Quarter Institutional Ownership Percentage
103.78%
Total Invested of Last Quarter
$5.43 M
Ownership Percentage of Last Quarter
7.16%
Context Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 08/13/2024 | 4.50 M | $9.03 M | 652.49% | 28.20% |
| GREAT POINT PARTNERS LLC | 08/14/2024 | 7.42 M | $14.88 M | 100.00% | 13.50% |
| AVIDITY PARTNERS MANAGEMENT LP | 08/14/2024 | 7.42 M | $14.88 M | 100.00% | 13.50% |
| DEEP TRACK CAPITAL, LP | 08/14/2024 | 7.42 M | $14.88 M | 100.00% | 13.50% |
| NEXTECH INVEST LTD. | 08/14/2024 | 7.42 M | $14.88 M | 100.00% | 13.50% |
| BLUE OWL CAPITAL HOLDINGS LP | 08/15/2024 | 5.16 M | $10.35 M | 100.00% | 9.39% |
| BLACKROCK INC. | 08/13/2024 | 851,696 | $1.71 M | 100.00% | 5.33% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/15/2024 | 2.26 M | $4.53 M | 100.00% | 4.11% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 618,174 | $1.24 M | 511.62% | 3.87% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/20/2024 | 1.94 M | $3.88 M | 100.00% | 3.52% |
| ALYESKA INVESTMENT GROUP, L.P. | 08/14/2024 | 1.94 M | $3.85 M | 100.00% | 3.52% |
| ALLY BRIDGE GROUP (NY) LLC | 08/14/2024 | 1.89 M | $3.78 M | 159.83% | 3.43% |
| BLACKSTONE INC. | 08/14/2024 | 1.84 M | $3.69 M | 100.00% | 3.35% |
| AFFINITY ASSET ADVISORS, LLC | 08/14/2024 | 1.62 M | $3.25 M | 392.41% | 2.95% |
| SIO CAPITAL MANAGEMENT, LLC | 08/14/2024 | 1.33 M | $2.66 M | 100.00% | 2.42% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 08/14/2024 | 1.29 M | $2.59 M | 100.00% | 2.35% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/13/2024 | 645,161 | $1.29 M | 213.29% | 1.17% |
| NORTHERN TRUST CORP | 08/14/2024 | 174,497 | $349,866 | 368.84% | 1.09% |
| HIGHTOWER ADVISORS, LLC | 08/13/2024 | 125,852 | $252,000 | 0.00% | 0.79% |
| ALTIUM CAPITAL MANAGEMENT LP | 08/15/2024 | 360,001 | $721,802 | 100.00% | 0.66% |
| STATE STREET CORP | 08/14/2024 | 92,107 | $184,675 | 179.90% | 0.58% |
| UBS OCONNOR LLC | 08/14/2024 | 293,758 | $588,985 | -0.98% | 0.53% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 65,200 | $130,726 | 63.41% | 0.41% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2024 | 41,469 | $83,145 | -60.81% | 0.26% |
| WALLEYE CAPITAL LLC | 08/14/2024 | 108,376 | $217,294 | 100.00% | 0.20% |
| MILL CREEK CAPITAL ADVISORS, LLC | 08/14/2024 | 104,631 | $209,785 | 0.00% | 0.19% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 13,844 | $27,757 | 100.00% | 0.09% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 10,776 | $21,606 | 100.00% | 0.07% |
| CLEAR HARBOR ASSET MANAGEMENT, LLC | 07/17/2024 | 36,000 | $72,180 | 0.00% | 0.07% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/13/2024 | 24,750 | $50,000 | 100.00% | 0.05% |
| CAXTON CORP | 08/14/2024 | 18,403 | $36,899 | 100.00% | 0.03% |
| VERITION FUND MANAGEMENT LLC | 08/14/2024 | 16,294 | $32,669 | 100.00% | 0.03% |
| ADVISOR GROUP HOLDINGS, INC. | 08/13/2024 | 500 | $1,003 | -66.67% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/14/2024 | 400 | $802 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| JEFFERIES FINANCIAL GROUP INC. | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| SHEETS SMITH WEALTH MANAGEMENT | 07/30/2024 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/15/2024 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/13/2024 | 0 | $0 | -100.00% | 0.00% |
| OPALEYE MANAGEMENT INC. | 08/14/2024 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 08/12/2024 | 0 | $0 | -100.00% | 0.00% |
Context Therapeutics Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CNTX shares?
During the previous two years, 46 institutional investors and hedge funds held shares of Context Therapeutics Inc.. The most heavily invested institutionals were:
GREAT POINT PARTNERS LLC: 7.42 M
Avidity Partners Management LP: 7.42 M
Nextech Invest Ltd.: 7.42 M
Deep Track Capital, LP: 7.42 M
Blue Owl Capital Holdings LP: 5.16 M
VANGUARD GROUP INC: 4.5 M
-
What percentage of Context Therapeutics Inc. stock is owned by institutional investors?
103.78% of Context Therapeutics Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CNTX ?
Institutional investors have bought a total of 57.25 M shares in the last 24 months. This purchase volume represents approximately $106.48 M in transactions.